tiprankstipranks
NeoGenomics (NEO)
NASDAQ:NEO
US Market
NEO
NeoGenomics
RESEARCH TOOLSreports

NeoGenomics (NEO) Income Statement

1,926 Followers

NeoGenomics Income Statement

Last quarter (Q4 2025), NeoGenomics's total revenue was $190.17M, an increase of 10.56% from the same quarter last year. In Q4, NeoGenomics's net income was $-9.88M. See NeoGenomics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 727.33M$ 660.57M$ 591.64M$ 509.73M$ 484.33M
Gross Profit
$ 282.54M$ 290.10M$ 244.60M$ 187.90M$ 187.06M
Operating Expenses
$ 348.62M$ 382.21M$ 352.34M$ 345.52M$ 305.81M
Depreciation and Amortization
$ 67.82M$ 72.55M$ 72.58M$ 69.43M$ 53.35M
EBITDA
$ 1.75M$ -1.51M$ -17.61M$ -82.33M$ -65.40M
Operating Income
$ -66.08M$ -92.11M$ -107.74M$ -157.62M$ -118.75M
Other Income/Expenses
$ -44.19M$ 11.43M$ 10.64M$ -1.72M$ 103.68M
Pretax Income
$ -110.27M$ -80.67M$ -97.10M$ -159.34M$ -15.07M
Net Income
$ -108.03M$ -78.73M$ -87.97M$ -144.25M$ -8.35M
Per Share Metrics
Basic EPS
$ -4.20$ -3.10$ -3.50$ -5.80$ -0.35
Diluted EPS
$ -4.20$ -3.10$ -3.50$ -5.80$ -0.35
Weighted Average Shares Outstanding
 25.62M 25.33M 25.10M 24.84M 23.99M
Weighted Average Shares Outstanding (Diluted)
 25.62M 25.33M 25.10M 24.84M 23.99M
Currency in USD

NeoGenomics Earnings and Revenue History